127 related articles for article (PubMed ID: 7114059)
21. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
Caldwell RD; Davis SK
Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
[TBL] [Abstract][Full Text] [Related]
22. Streamlining antimicrobial therapy through pharmacists' review of order sheets.
Briceland LL; Lesar TS; Lomaestro BM; Lombardi TP; Gailey RA; Kowalsky SF
Am J Hosp Pharm; 1989 Jul; 46(7):1376-80. PubMed ID: 2757043
[TBL] [Abstract][Full Text] [Related]
23. Financial impact of an aminoglycoside substitution program.
Andrews JD; Stad K
Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1982 Jun; 21(6):963-7. PubMed ID: 6921959
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of process and outcome assessment in antibiotic therapy.
Ilersich AL; Rovers JP; Einarson TR
Can J Hosp Pharm; 1991 Oct; 44(5):251-8, 270. PubMed ID: 10115579
[TBL] [Abstract][Full Text] [Related]
26. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of an antibiotic cost containment measure.
Jung B; Andrews JD
Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
[TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
Khanderia U
Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of carbenicillin disodium, cefazolin sodium, cephalothin sodium, nafcillin sodium, and ticarcillin disodium by high-pressure liquid chromatography.
Gupta VD; Stewart KR
J Pharm Sci; 1980 Nov; 69(11):1264-7. PubMed ID: 7452453
[TBL] [Abstract][Full Text] [Related]
31. Effect of clinical pharmacy services on prescribing on an orthopedic unit.
Herfindal ET; Bernstein LR; Kishi DT
Am J Hosp Pharm; 1983 Nov; 40(11):1945-51. PubMed ID: 6650524
[TBL] [Abstract][Full Text] [Related]
32. [A utilization review program of cefoxitin].
Desautels N; Fillion A; Girouard Y; Denis R; Désaulniers G
Can J Surg; 1991 Dec; 34(6):607-13. PubMed ID: 1747841
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravenous carbenicillin, cefoxitin and cefamandole on ADP-induced platelet aggregation and shape change.
Fedder IL; Holme S; Vlasses PH; Ferguson RK; Murphy S
Thromb Res; 1983 Oct; 32(2):215-22. PubMed ID: 6658713
[TBL] [Abstract][Full Text] [Related]
34. The effect of an education program on cefazolin prescribing.
Blain L; O'Brodovich M
Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923
[TBL] [Abstract][Full Text] [Related]
35. Appropriate but not cost effective ceftazidime use in a university hospital.
Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
[TBL] [Abstract][Full Text] [Related]
36. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
[TBL] [Abstract][Full Text] [Related]
37. Monitoring waste in an intravenous admixture program.
Mitchell SR
Am J Hosp Pharm; 1987 Jan; 44(1):106-11. PubMed ID: 3826083
[TBL] [Abstract][Full Text] [Related]
38. Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
Lawson RD; Estey EH; Bodey GP
Am J Med; 1983 Aug; 75(2A):113-8. PubMed ID: 6310998
[TBL] [Abstract][Full Text] [Related]
39. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
Kjeldby C; Bjerre A; Refsum N
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacist impact on parenteral cephalosporin prescribing.
Lawlor MC; Lucarotti RL
Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
